Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell P Hall

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Plos One|June 20, 2020
Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximabSravya M Bhatia, Robert D Streilein, Russell P Hall
Archives of Dermatology|March 17, 2004
Localized facial macules and vesiclesAndrew L Kaplan, Linda H Lee, Russell P Hall
The Journal of Investigative Dermatology|February 14, 2012
Happy birthday, Society for Investigative DermatologyAlice P Pentland, Russell P Hall, Kim B Yancey
The Journal of Investigative Dermatology|August 15, 2014
Keratinocyte growth regulation TRP-ed up over downregulated TRPV4?Wolfgang Liedtke, Jennifer Y Zhang, Russell P Hall, et al.
The Journal of Investigative Dermatology|April 1, 2006
Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-Selectin, and TNF-alphaRussell P Hall, Fumiko Takeuchi, Keith M Benbenisty, et al.
The Journal of Investigative Dermatology|February 4, 2011
c-Jun promotes whereas JunB inhibits epidermal neoplasiaJane Y Jin, Hengning Ke, Russell P Hall, et al.
Plos One|September 26, 2018
Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysisAshwin Agarwal, Russell P Hall, Lionel L Bañez, et al.
The Journal of Investigative Dermatology|June 17, 2006
Picking your peersLowell A Goldsmith, Elizabeth N Blalock, Heather Bobkova, et al.
Dermatologic Clinics|September 20, 2011
Evidence-based management of bullous pemphigoidBenjamin S Daniel, Luca Borradori, Russell P Hall, et al.
Pediatric Dermatology|September 30, 2005
Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab)Heidi H Kong, Neil S Prose, Russell E Ware, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Plos One|June 20, 2020
Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximabSravya M Bhatia, Robert D Streilein, Russell P Hall
Archives of Dermatology|March 17, 2004
Localized facial macules and vesiclesAndrew L Kaplan, Linda H Lee, Russell P Hall
The Journal of Investigative Dermatology|February 14, 2012
Happy birthday, Society for Investigative DermatologyAlice P Pentland, Russell P Hall, Kim B Yancey
The Journal of Investigative Dermatology|August 15, 2014
Keratinocyte growth regulation TRP-ed up over downregulated TRPV4?Wolfgang Liedtke, Jennifer Y Zhang, Russell P Hall, et al.
The Journal of Investigative Dermatology|April 1, 2006
Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-Selectin, and TNF-alphaRussell P Hall, Fumiko Takeuchi, Keith M Benbenisty, et al.
The Journal of Investigative Dermatology|February 4, 2011
c-Jun promotes whereas JunB inhibits epidermal neoplasiaJane Y Jin, Hengning Ke, Russell P Hall, et al.
Plos One|September 26, 2018
Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysisAshwin Agarwal, Russell P Hall, Lionel L Bañez, et al.
The Journal of Investigative Dermatology|June 17, 2006
Picking your peersLowell A Goldsmith, Elizabeth N Blalock, Heather Bobkova, et al.
Dermatologic Clinics|September 20, 2011
Evidence-based management of bullous pemphigoidBenjamin S Daniel, Luca Borradori, Russell P Hall, et al.
Pediatric Dermatology|September 30, 2005
Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab)Heidi H Kong, Neil S Prose, Russell E Ware, et al.
Pageof 7